[{"address1": "321 Harrison Avenue", "address2": "8th Floor", "city": "Boston", "state": "MA", "zip": "02118", "country": "United States", "phone": "781 797 0979", "website": "https://pepgen.com", "industry": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "PepGen Inc., a clinical-stage biotechnology company, focuses on the development of oligonucleotide therapeutics for use in the treatment of severe neuromuscular and neurologic diseases. Its lead product candidate is PGN-EDO51, an EDO peptide that is in Phase 2 clinical trial to treat Duchenne muscular dystrophy (DMD) patients. The company is also developing PGN-EDODM1, an EDO peptide-conjugated PMO, which is in Phase 1 clinical trial for the treatment of myotonic dystrophy type 1, as well as EDO therapeutic candidates, such as PGN-EDO53, PGN-EDO45, and PGN-EDO44 for the treatment of DMD. PepGen Inc. was founded in 2018 and is based in Boston, Massachusetts.", "fullTimeEmployees": 72, "companyOfficers": [{"maxAge": 1, "name": "Dr. James G. McArthur Ph.D.", "age": 61, "title": "President, CEO, Treasurer, Secretary & Director", "yearBorn": 1962, "fiscalYear": 2023, "totalPay": 810700, "exercisedValue": 0, "unexercisedValue": 934790}, {"maxAge": 1, "name": "Mr. Noel P. Donnelly M.B.A.", "age": 53, "title": "Chief Financial Officer", "yearBorn": 1970, "fiscalYear": 2023, "totalPay": 604241, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Michelle L. Mellion M.D.", "age": 47, "title": "Chief Medical Officer", "yearBorn": 1976, "fiscalYear": 2023, "totalPay": 507806, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Michael  Gait Ph.D.", "title": "Founder & Scientific Advisory Board Member", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. David E. Borah C.F.A.", "title": "Senior VP of IR & Corporate Communications", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Mary Beth DeLena J.D.", "age": 55, "title": "General Counsel & Secretary", "yearBorn": 1968, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Niels  Svenstrup Ph.D.", "age": 53, "title": "Senior Vice President of Chemistry, Manufacturing & Control", "yearBorn": 1970, "fiscalYear": 2023, "totalPay": 455150, "exercisedValue": 0, "unexercisedValue": 168610}, {"maxAge": 1, "name": "Ms. Emiko  Bryant", "title": "Chief of Staff", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Hayley  Parker Ph.D.", "title": "Senior Vice President of Global Regulatory Affairs", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Afsaneh  Mohebbi Ph.D.", "title": "Senior VP of Portfolio and Program Management", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 2, "boardRisk": 5, "compensationRisk": 8, "shareHolderRightsRisk": 8, "overallRisk": 6, "governanceEpochDate": 1730419200, "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 2, "previousClose": 6.62, "open": 6.62, "dayLow": 6.36, "dayHigh": 6.82, "regularMarketPreviousClose": 6.62, "regularMarketOpen": 6.62, "regularMarketDayLow": 6.36, "regularMarketDayHigh": 6.82, "beta": 1.69, "forwardPE": -2.2978723, "volume": 34364, "regularMarketVolume": 34364, "averageVolume": 112335, "averageVolume10days": 32140, "averageDailyVolume10Day": 32140, "bid": 4.79, "ask": 8.32, "bidSize": 200, "askSize": 200, "marketCap": 211181264, "fiftyTwoWeekLow": 3.72, "fiftyTwoWeekHigh": 19.298, "fiftyDayAverage": 8.8128, "twoHundredDayAverage": 12.493275, "currency": "USD", "enterpriseValue": 69287272, "floatShares": 15477827, "sharesOutstanding": 32589700, "sharesShort": 872505, "sharesShortPriorMonth": 973577, "sharesShortPreviousMonthDate": 1726185600, "dateShortInterest": 1728950400, "sharesPercentSharesOut": 0.026800001, "heldPercentInsiders": 0.00017999999, "heldPercentInstitutions": 0.92509, "shortRatio": 9.69, "shortPercentOfFloat": 0.051, "bookValue": 4.763, "priceToBook": 1.3604871, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1719705600, "netIncomeToCommon": -89140000, "trailingEps": -3.31, "forwardEps": -2.82, "enterpriseToEbitda": -0.734, "exchange": "NMS", "quoteType": "EQUITY", "symbol": "PEPG", "underlyingSymbol": "PEPG", "shortName": "PepGen Inc.", "longName": "PepGen Inc.", "firstTradeDateEpochUtc": 1651843800, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EST", "uuid": "d8556119-2e86-3dba-8e6a-e25559b6dab2", "gmtOffSetMilliseconds": -18000000, "currentPrice": 6.48, "targetHighPrice": 26.0, "targetLowPrice": 10.0, "targetMeanPrice": 19.6, "targetMedianPrice": 21.0, "recommendationMean": 1.6, "recommendationKey": "buy", "numberOfAnalystOpinions": 5, "totalCash": 161306000, "totalCashPerShare": 4.95, "ebitda": -94365000, "totalDebt": 19412000, "quickRatio": 7.297, "currentRatio": 7.454, "debtToEquity": 12.521, "returnOnAssets": -0.31886998, "returnOnEquity": -0.5897, "freeCashflow": -44687752, "operatingCashflow": -74993000, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-11-04"}]